Yao, Y.; Yang, X.; Li, J.; Guo, E.; Wang, H.; Sun, C.; Hong, Z.; Zhang, X.; Jia, J.; Wang, R.;
et al. Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody. Pharmaceuticals 2025, 18, 395.
https://doi.org/10.3390/ph18030395
AMA Style
Yao Y, Yang X, Li J, Guo E, Wang H, Sun C, Hong Z, Zhang X, Jia J, Wang R,
et al. Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody. Pharmaceuticals. 2025; 18(3):395.
https://doi.org/10.3390/ph18030395
Chicago/Turabian Style
Yao, Yunqi, Xiaoning Yang, Jing Li, Erhong Guo, Huiyu Wang, Chunyun Sun, Zhangyong Hong, Xiao Zhang, Jilei Jia, Rui Wang,
and et al. 2025. "Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody" Pharmaceuticals 18, no. 3: 395.
https://doi.org/10.3390/ph18030395
APA Style
Yao, Y., Yang, X., Li, J., Guo, E., Wang, H., Sun, C., Hong, Z., Zhang, X., Jia, J., Wang, R., Ma, J., Dai, Y., Deng, M., Yu, C., Sun, L., & Xie, L.
(2025). Preclinical Characterization of Efficacy and Pharmacodynamic Properties of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody. Pharmaceuticals, 18(3), 395.
https://doi.org/10.3390/ph18030395